Orphan Medical Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
80
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
6
Orphan Medical General Information
Description
Developer of drugs created to treat sleep disorders diseases. The company develops specialty drugs for the treatment of sleep disorders, pain and other central nervous system disorders.
Contact Information
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 13911 Ridgedale Drive
- Suite 250
- Minnetonka, MN 55305
- United States
Orphan Medical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Orphan Medical Patents
Orphan Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2005282468-B2 | Improved ghb compositions | Inactive | 07-Sep-2004 | 0000000000 | |
| AU-2005282468-A1 | Improved ghb compositions | Active | 07-Sep-2004 | 0000000000 | |
| CA-2579576-A1 | Improved ghb compositions | Inactive | 07-Sep-2004 | 0000000000 | |
| EP-1786437-A2 | Improved ghb compositions | Inactive | 07-Sep-2004 | 0000000000 | |
| EP-1786437-A4 | Improved ghb compositions | Inactive | 07-Sep-2004 | A61K31/191 | 0 |
Orphan Medical Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Orphan Medical Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|